Professor Anastasios Karadimitris
Co-Director Centre for Haematology, Professor of Haematology
Faculty of Medicine, Department of Immunology and Inflammation
Professor Anastasios Karadimitris' inventions
Invariant Natural Killer T cell (iNKT cell) engagers
An immunotherapy platform capable of enhancing the anti-tumour efficacy of invariant natural killer T cells (iNKT). Further information on this technology
anti-TCRVbeta Chimeric Antigen Receptors (CARs)
anti-TCRVbeta Chimeric Antigen Receptors which can target pathological T cells in a highly selective manner, leaving >90% of the patient's T cells and T cell-dependent immunity intact. Further information on this technology
Sign up for updates
Sign up for monthly technology alerts via email, and find other ways to connect with us.